Clinical Trial Imaging Platforms Compared: Collective Minds vs. Clario, ICON, Medidata, Perceptive, AG Mednet

In a growing number of trials, imaging is the evidence. When the primary endpoint depends on a scan, the platform you use to collect, review, and quality-check that imaging shapes how fast the study moves and how much you can trust the result. Yet most sponsors and CROs don't choose an imaging platform in isolation. They inherit one inside a larger suite, or bundle it with a full-service CRO, and imaging becomes one line item among dozens.

That choice carries more weight than it used to. Oncology trials lean on RECIST and central review. Neurology and cardiology programs increasingly hang their conclusions on quantitative imaging. Regulators expect a clean, traceable path from the scanner to the reported endpoint. When imaging is the thing the trial rests on, a slow or fragmented imaging workflow does not just add cost. It delays database lock, triggers repeat scans, and puts the reliability of the endpoint at risk.

This guide compares the main options for imaging in clinical trials side by side: Clario, ICON Plc, Medidata Rave Imaging, Perceptive (formerly Invicro), and AG Mednet (Judi), and how each compares with Collective Minds Research. The goal is simple. Less friction, stronger evidence. Use it to see which model fits a trial where imaging endpoints drive the outcome.

The core distinction: bundled suite or specialist imaging network

Almost every option below falls into one of two camps.

• The bundled model. Full-service CROs and integrated eClinical suites offer imaging as part of a much larger scope. The appeal is a single vendor for the whole trial. The trade-off is that imaging is one function within a much larger system, and it tends to move at the pace of the suite around it.
• The specialist model. A dedicated imaging platform does one thing and builds everything around it: getting images from the scanner to the reviewer, keeping quality high, and letting experts collaborate in real time. The trade-off is that it is not a one-stop shop for every trial function.

The distinction matters because imaging has its own failure modes. A protocol deviation at the scanner, a missing series, an inconsistent acquisition across sites: these problems are cheap to fix on the day of the scan and expensive to fix months later. A bundled suite often reviews imaging later and in batch, once the data has moved through several hand-offs. A specialist platform is built to catch these issues early, while the patient is still in reach and the scan can still be repeated.

Collective Minds Research is the specialist. It is a network-first, cloud-native imaging platform with a single unified codebase, a pre-connected network of 300+ imaging sites, and access to 30,000+ imaging experts across 30+ countries. Where a bundled suite treats imaging as one part of a wider program, Collective Minds Research is built for trials where the image is the primary data source. The rest of this guide looks at each alternative in turn, then sets out what to look for when the imaging endpoint is what the trial depends on.

The platforms at a glance

Clario

Clario is the consolidated industry leader for multi-endpoint data collection, formed from years of mergers across the eClinical space. Its strength is breadth: imaging alongside cardiac safety, respiratory, and patient-reported outcomes in one integrated suite. That makes it a strong fit for large, multi-endpoint programs where imaging is one of several data streams to manage under one roof.

The consideration is the one that comes with any broad platform. Imaging is one capability among many, and it follows the pace and the architecture of the wider suite. For a program where imaging is a secondary endpoint, that breadth is an advantage. For a trial where the image is the primary evidence and turnaround time is critical, a platform built solely around imaging speed and reviewer collaboration tends to move faster.

ICON Plc

ICON is a full-service CRO with 40,000+ employees following its acquisition of PRA. It runs trials end to end, from site selection to regulatory submission, with imaging as one specialized service inside a very large organization. Sponsors choose ICON for scale and the convenience of bundling every function with a single partner. The consideration is that imaging is one service among many, and its pace reflects that scale.

Bundling everything with one CRO simplifies contracting and gives a single point of accountability, which is a real advantage for many programs. It also means the imaging endpoint is one priority among many service lines. Teams that need imaging to move quickly, or that want deep imaging expertise on demand, sometimes pair a full-service CRO with a specialist imaging platform rather than relying on the bundle alone.

Medidata Rave Imaging

Medidata Rave Imaging adds imaging capability to the broader Medidata Rave ecosystem for end-to-end clinical trial management. For organizations already standardized on Medidata across EDC and trial operations, keeping imaging in the same environment is a genuine benefit. The platform is built around comprehensive trial management first, with imaging as an integrated function rather than the core focus.

If your team already lives in Rave, the integration story is real and worth weighing. The question to ask is whether an imaging function inside a trial-management suite gives central readers the speed, the viewing tools, and the real-time collaboration that an imaging-first platform is designed for. When imaging drives the endpoint, the depth of the imaging workflow usually matters more than sharing one environment with the EDC.

Perceptive (formerly Invicro)

Perceptive is a large full-service CRO formed when Invicro merged with Calyx in 2024. It offers end-to-end drug development services across phases I to IV, including imaging alongside services like supply management and eClinical platforms. Its history includes scale most vendors cannot match: 12,000+ trials and 800+ regulatory approvals. That breadth brings together technology from several acquisitions, with reader capacity tied to internal staff.

Deep therapeutic experience and a long regulatory track record are genuine strengths for complex programs. The considerations are the ones common to large, full-service organizations: integrating technology across several business lines, and reader capacity that follows internal headcount. When a trial needs to scale reads quickly or reach a specific subspecialty, a network model that draws on tens of thousands of experts flexes in a way a fixed internal team cannot.

AG Mednet (Judi)

Judi, by AG Mednet, is a workflow orchestration platform. It manages the administrative lifecycle of a trial: sites upload files to a submission portal, and the system routes them to the right reviewers and adjudication committees. It works as a traffic controller across therapeutic areas, and it does that job well. Its focus is submission tracking and administrative routing rather than the images themselves.

For trials where the main challenge is administrative, tracking submissions, managing forms, and coordinating adjudication, that orchestration is valuable. The consideration is that it is built around the administrative flow of the trial rather than the images. Sites still upload manually, and review is sequential and form-based. When teams need central readers to see and annotate the actual images in near real time, an imaging platform that streams data straight from the modality adds capability the submission-portal model is not designed for.

Collective Minds Research

Collective Minds Research is a specialist imaging platform for clinical trials. Instant Data Access connects scanners directly to the central review platform, so imaging becomes available in minutes instead of days and quality issues are caught while a scan can still be repeated. Sites onboard through a pre-connected network rather than a lengthy technical setup, and reads scale across a global network of experts rather than a fixed internal team. It is built for one job: moving faster to reliable imaging endpoints without cutting a scientific corner.

Clinical trial imaging platforms compared

The table below sets each platform against the criteria that matter most when imaging drives the endpoint.

What to look for when imaging drives the endpoint

Whichever platform you compare, four things separate an imaging workflow that helps the trial from one that slows it down. They map to what Collective Minds is built to deliver: speed, control, science, and compliance.

Data access and speed

The single biggest difference between platforms is how images get from the scanner to the reviewer. Traditional models rely on manual upload to a portal, followed by batch transfer and review days or weeks later. Instant Data Access connects the modality directly to the platform, so imaging is available in minutes. That speed is not a convenience. It compresses the time to imaging endpoints and shortens the whole review cycle, which is what moves database lock forward.

Quality control while it still matters

Every imaging trial deals with protocol deviations, missing series, and inconsistent acquisition across sites. The question is when you find them. Catch a problem in near real time and the site can repeat the scan while the patient is still available. Catch it in a batch review months later and you are left with a query, a missing timepoint, or a weakened dataset. Early quality control is one of the clearest advantages of an imaging-first platform over a suite that reviews imaging in bulk.

Reader model and network

Full-service CROs read with internal staff, so capacity is tied to headcount and specific subspecialties can be hard to source at short notice. A network model works differently. Collective Minds Research draws on 30,000+ imaging experts across 300+ connected sites in 30+ countries, so reads scale with the trial and the right expertise is available when a protocol calls for it. Real-time, concurrent review also lets central readers view and annotate the same images together, rather than passing files through a sequential queue.

Control, compliance, and the audit trail

Removing friction cannot mean loosening rigor. Sponsors need to keep control of their imaging data throughout the study, with a clean audit trail from acquisition to reported endpoint. A specialist platform built for trials treats traceability, anonymization, and validated workflows as core features rather than add-ons, so the same speed that shortens the timeline also stands up to regulatory scrutiny.

Matching the platform to your trial

The decision usually comes down to the role imaging plays in the study.

Imaging is one endpoint among several. If the trial collects imaging alongside cardiac safety, respiratory, and patient-reported outcomes, and no single imaging endpoint decides the result, a bundled suite or full-service CRO can be the simpler route. One vendor, one contract, imaging handled inside the wider program.

Imaging is the primary evidence. If the endpoint depends on central read, quality has to be caught early, and turnaround time affects the timeline, a specialist imaging platform is usually the faster path to a reliable result. Many teams combine the two: a full-service CRO or suite for the broad trial functions, and Collective Minds Research for the imaging endpoint where speed and reviewer quality matter most.

Things you might be wondering

Can I use Collective Minds Research alongside a full-service CRO?

Yes. Many teams run a best-of-breed setup: a large CRO handles the broad trial functions, and Collective Minds Research handles imaging where speed and reviewer quality matter most. The specialist platform slots into the imaging endpoint without replacing the rest of the program.

Do I lose scale or global reach by choosing a specialist?

No. Reach comes from the network, not from headcount. Collective Minds Research draws on 30,000+ imaging experts across 300+ connected sites in 30+ countries, so reads scale up or down with the trial instead of being capped by a fixed internal team.

What about regulatory compliance?

Compliance is built in, not bolted on. The platform supports validated, traceable workflows with the controls trials require, so removing friction never means loosening scientific or regulatory rigor.

How does Instant Data Access change the timeline?

Instead of waiting for sites to upload images manually and for reviews to happen in batch, images stream from the scanner to the platform and become available in minutes. Central readers work from current data, quality issues surface early, and the review cycle that usually sits on the critical path gets shorter.

Is a specialist platform only for large trials?

No. The model fits any trial where imaging is the primary data source, from agile BioTech and MedTech studies to large multi-site programs. Because sites connect through a pre-connected network rather than a long technical setup, smaller teams reach a working imaging workflow quickly.

When does a bundled suite make more sense?

When imaging is a minor endpoint and the priority is a single vendor for every trial function, a bundled suite or full-service CRO can be the simpler choice. When the image is the evidence, a specialist platform is usually the faster path to a reliable endpoint.

Choosing the right imaging partner

The right choice comes down to the role imaging plays in your trial. If imaging is one of many endpoints inside a broad program, a bundled suite or full-service CRO keeps everything with one vendor. If imaging is the endpoint that determines whether the trial succeeds, a specialist network gets you to reliable evidence faster, with quality caught early and experts available on demand.

See how Collective Minds Research compares for your study.